山西汾酒(600809.SH):1-2月預計實現淨利潤27億元以上
格隆匯3月9日丨山西汾酒(600809.SH)公佈2022年1-2月經營情況公吿,2022年,公司持續聚集品牌勢能,全面提升運營效率,各銷售區域克服疫情影響,提前佈局春節旺季,整體市場動銷良好,青花汾酒系列等中高端產品實現大幅增長,營業收入及淨利潤均實現歷史最好水平。經初步核算,2022年1-2月,公司預計實現營業總收入74億元以上,同比增長35%以上;預計實現歸屬於上市公司股東的淨利潤27億元以上,同比增速超過50%以上。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.